CME Group Inc. (NASDAQ:CME)‘s stock had its “buy” rating restated by analysts at Jefferies Group in a report issued on Thursday. They presently have a $118.00 price objective on the stock. Jefferies Group’s target price indicates a potential upside of 13.17% from the stock’s current price.
Several other brokerages have also recently commented on CME. Deutsche Bank AG increased their target price on CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a report on Friday, August 5th. JPMorgan Chase & Co. increased their target price on CME Group from $99.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 29th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Credit Agricole SA decreased their target price on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a report on Thursday, July 14th. Finally, Keefe, Bruyette & Woods increased their target price on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $103.27.
Shares of CME Group (NASDAQ:CME) traded down 0.65% during midday trading on Thursday, hitting $103.59. 324,781 shares of the company were exchanged. CME Group has a one year low of $81.87 and a one year high of $110.35. The company’s 50 day moving average price is $106.54 and its 200 day moving average price is $99.60. The firm has a market cap of $35.10 billion, a P/E ratio of 26.16 and a beta of 0.83.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm had revenue of $906 million for the quarter, compared to analysts’ expectations of $897.84 million. During the same period in the prior year, the business posted $0.95 earnings per share. The business’s revenue was up 10.5% compared to the same quarter last year. Equities analysts expect that CME Group will post $4.43 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 2.30%. The ex-dividend date was Wednesday, September 7th. CME Group’s payout ratio is 60.61%.
In other CME Group news, insider Hilda Harris Piell sold 893 shares of the stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $110.00, for a total value of $98,230.00. Following the completion of the sale, the insider now directly owns 29,125 shares in the company, valued at $3,203,750. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Phupinder Gill sold 20,080 shares of the stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $104.54, for a total value of $2,099,163.20. Following the completion of the sale, the chief executive officer now owns 154,141 shares of the company’s stock, valued at $16,113,900.14. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.
Several large investors have recently made changes to their positions in CME. Bank of Montreal Can acquired a new stake in shares of CME Group during the second quarter valued at about $35,643,000. Legal & General Group Plc increased its stake in shares of CME Group by 2.0% in the first quarter. Legal & General Group Plc now owns 1,391,482 shares of the company’s stock valued at $133,643,000 after buying an additional 27,322 shares during the period. AMP Capital Investors Ltd increased its position in CME Group by 10.6% in the first quarter. AMP Capital Investors Ltd now owns 278,973 shares of the company’s stock worth $26,661,000 after buying an additional 26,751 shares during the last quarter. UMB Bank N A MO increased its position in CME Group by 5.8% in the second quarter. UMB Bank N A MO now owns 177,713 shares of the company’s stock worth $17,309,000 after buying an additional 9,775 shares during the last quarter. Finally, Strs Ohio increased its position in CME Group by 5.2% in the second quarter. Strs Ohio now owns 234,783 shares of the company’s stock worth $22,867,000 after buying an additional 11,596 shares during the last quarter. Institutional investors own 80.29% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.